Curileum Discovery
Pre-clinicalCurileum is developing novel therapies that restore the health of gastrointestinal (GI) tissues to prevent bowel cancer and treat IBD.
Founded
2018
Focus
Small Molecules
About
Curileum is developing novel therapies that restore the health of gastrointestinal (GI) tissues to prevent bowel cancer and treat IBD.
Funding History
1Total raised: $1.8M
Seed$1.8MUK Innovation & Science Seed FundSep 15, 2022
Company Info
TypePrivate
Founded2018
LocationCambridge, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile